7 / 12
Page 29
Journal of Clinical Immunology and Allergy
ISSN: 2471-304X
E u r o p e a n C o n g r e s s o n
Vaccines & Vaccination
and Gynecologic Oncology
Vaccines & Vaccination and Gynecologic Oncology 2018
O c t o b e r 2 6 - 2 7 , 2 0 1 8
B u d a p e s t , H u n g a r y
Biography
Jeanne Moldenhauer, Vice-President of Excellent Pharma
Consulting has more than 30 years’ experience in the
pharmaceutical industry. She chaired the Environmental
Monitoring/Microbiology Interest Group of PDA for more than
15 years, served on the Scientific Advisory Board of PDA for 20
years, founded the Rapid Microbiology User’s Group™, and is a
Member of ASQ and RAPS. She is the author of many books
and numerous publications (book chapters and magazine
articles).
jeannemoldenhauer@gmail.comDeveloping an environmental control program for vaccines
Jeanne Moldenhauer
Excellent Pharma Consulting, Inc
Jeanne Moldenhauer, Journal of Clinical Immunology and Allergy, Volume: 4
DOI: 10.21767/2471-304X-C2-005
I
n this every changing world of regulatory expectations, developing a regulatory
strategy for environmental control can be challenging. This talk will discuss
current expectations for environmental control and will also provide guidance on
regulatory issues associated with these programs.
Euro Vaccines 2018